Related Experiment Videos

Difference in the in-hospital prognosis between ST-segment elevation myocardial infarction and non-ST-segment

Motoki Fukutomi1, Kensaku Nishihira2, Satoshi Honda2

  • 1Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, Japan.

Insights

ST-segment elevation myocardial infarction (STEMI) has worse outcomes than non-ST-segment elevation myocardial infarction (NSTEMI) in high Killip class patients, particularly the elderly. Younger patients showed no significant difference in short-term outcomes between STEMI and NSTEMI.

Area of Science:

  • Cardiology
  • Acute Myocardial Infarction Research
  • Geriatric Cardiology

Background:

  • ST-segment elevation myocardial infarction (STEMI) generally has a worse short-term prognosis than non-ST-segment elevation myocardial infarction (NSTEMI).
  • The comparative outcomes of STEMI versus NSTEMI in patients with high Killip class (II-IV) have remained unclear.
  • High Killip class indicates severe left ventricular dysfunction and carries a poor prognosis in acute myocardial infarction (AMI).

Purpose of the Study:

  • To investigate the short-term outcomes of STEMI compared to NSTEMI in patients presenting with high Killip class (II-IV).
  • To evaluate the influence of age on the comparative outcomes between STEMI and NSTEMI in this high-risk AMI population.

Main Methods:

  • Analysis of 3704 acute myocardial infarction patients with Killip II-IV class from the Japan Acute Myocardial Infarction Registry.
  • Comparison of short-term outcomes, including in-hospital mortality, between STEMI (n=2943) and NSTEMI (n=761) groups.
  • Subgroup analysis based on age: <80 years and ≥80 years.

Main Results:

  • Overall, no significant difference in in-hospital mortality between STEMI and NSTEMI groups (20.0% vs 17.1%, p=0.065).
  • In patients <80 years, in-hospital mortality was similar between STEMI (15.7%) and NSTEMI (15.2%) groups (p=0.807).
  • In patients ≥80 years, STEMI was associated with significantly higher in-hospital mortality (29.3% vs 19.8%, p=0.001) and cardiac mortality (23.3% vs 15.0%, p=0.002) compared to NSTEMI.

Conclusions:

  • In high Killip class AMI patients, STEMI does not confer worse short-term outcomes than NSTEMI in younger individuals.
  • Elderly patients (≥80 years) with high Killip class AMI experience significantly worse short-term outcomes with STEMI compared to NSTEMI.
  • Further research is needed to identify prognostic factors and optimize intensive care for this high-risk elderly AMI subgroup.
Abstract

Related Concept Videos